Thomas Patrick Kelly, CFO: Xenon Pharmaceuticals XENE Buy · Filed 10/01

Trade details

Type: Insider buy
Amount: $559,740
Shares · price: 15,000 sh · $37.32 a share
Held after: 15,000 sh
Stock: Xenon Pharmaceuticals XENE
Person: Thomas Patrick KellyCFO
Trade date: 26/09/30
Filed: 26/10/01
Days to filing: 1 days

First buy since 2023

Insiders buying this week: 2 insiders

Xenon Pharmaceuticals trades, last 26 weeks

What else happened in Xenon Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 08/31~10/30

Thomas Patrick Kelly's recent trades

Thomas Patrick KellyCFO
SellDeciphera Pharmaceuticals
Sell
Deciphera Pharmaceuticals
DCPH
$47K
3,010 sh
$47K
Filed 24/02/20
Traded 24/02/16
Thomas Patrick KellyCFO
SellDeciphera Pharmaceuticals
Sell
Deciphera Pharmaceuticals
DCPH
$35.2K
2,435 sh
$35.2K
Filed 24/01/18
Traded 24/01/16
Thomas Patrick KellyCFO
SellDeciphera Pharmaceuticals
Sell
Deciphera Pharmaceuticals
DCPH
$42.9K
2,792 sh
$42.9K
Filed 23/12/14
Traded 23/12/13
Thomas Patrick KellyCFO
SellDeciphera Pharmaceuticals
Sell
Deciphera Pharmaceuticals
DCPH
$27.8K
2,316 sh
$27.8K
Filed 23/10/31
Traded 23/10/30
Thomas Patrick KellyCFO
SellDeciphera Pharmaceuticals
Sell
Deciphera Pharmaceuticals
DCPH
$23.8K
1,655 sh
$23.8K
Filed 23/06/21
Traded 23/06/16